Blockchain advancements to come from Tjoapack and Veratrak partnership

By Maggie Lynch contact

- Last updated on GMT

(Image:Getty/it_exx)
(Image:Getty/it_exx)

Related tags: Blockchain, Packaging, Packaging and labeling, Data

Tjoapack and Veratrak partnered to establish the use of blockchain technology across the pharmaceutical industry for the first time in a GxP environment.

Tjoapack a global packaging organization (CPO) will work with Veratrak, a UK-based technology company, on projects that use blockchain properties for transparent data collaboration across pharmaceutical supply chains. According to the company the partnership will initiate projects using blockchain properties more secure.

According to Dexter Tjoa, director of corporate strategy at Tjoapack, “We’re addressing the need for closer collaboration within the pharmaceutical industry by enabling easier and more transparent sharing of data in the form of master data, artwork, and batch records.”

The company will address this need for closer collaboration through multiple projects. The first project will use Vertrack’s document collaboration tool that uses blockchain properties to secure dating sharing.

“The tool will greatly reduce the lead time for new stock keeping unit (SKUs) and implementation time for product changes (such as artwork changes). This will enable us to become more flexible and reduce time to market for our customers”, ​explained Tjoa.

Veratrak’s tool has been built according to GAMP5 guidelines and is compliant with FDA part 11 regulations, according to the company.

According to a press release from Tjoapack, Veratrak’s tool will be the first global application of blockchain in a “Good practice (GxP) environment working with multiple organizations in the supply chain.”

Toja also told us that “Blockchain [technology] has other benefits for the industry than the above use case and we’ll be exploring this in the coming months and years together with Veratrak.”

Related news

Show more

Related products

show more

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us

Products

View more

Webinars